Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs. – Self
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs. Self
Telix’s new lead-212 generator could dispel medical isotope scalability hurdles
Whilst showing promise in cancer therapies, lead-212-based alpha emitters are hard to commercially supply.
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults – Business Wire
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant…
Scientists find natural molecule that works like Ozempic – The Hill
Scientists find natural molecule that works like Ozempic The Hill
You don’t need Ozempic for weight loss—let your meals do the work – Onmanorama
You don’t need Ozempic for weight loss—let your meals do the work Onmanorama
Microdosing Weight-Loss Drugs Goes Viral, and Worries Experts – Bloomberg
Microdosing Weight-Loss Drugs Goes Viral, and Worries Experts Bloomberg
Regulators vs weight loss ads: Time to rethink the rules? – pharmaphorum
Regulators vs weight loss ads: Time to rethink the rules? pharmaphorum
UConn gene discovery moves closer to treating neuromuscular disease, holds promise for weight loss – Hartford Courant
UConn gene discovery moves closer to treating neuromuscular disease, holds promise for weight loss Hartford Courant
The unintended consequences of weight-loss drugs – Spectrum News 1
The unintended consequences of weight-loss drugs Spectrum News 1
Atsena’s ATSN-201 gains FDA fast track status for XLRS treatment
Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked…